STOCK TITAN

DNA X delays Q3 report; continuing loss seen near $1.3M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
NT 10-Q

Rhea-AI Filing Summary

DNA X, Inc. expects to file its Form 10-Q for the three months ended September 30, 2026, on or before the fifth calendar day following the prescribed due date. The delay reflects additional work to determine the accounting for preferred stock issued to a related party for cash and cancellation of outstanding indebtedness, including whether the stock should be classified as mezzanine equity or permanent equity.

The company expects to report a net loss from continuing operations of approximately $1.3 million, compared with approximately $2.2 million for the corresponding 2025 period. It attributed the expected decrease to approximately $0.5 million in prior-year interest expense on promissory notes paid off in January 2026 and $0.4 million in prior-year legal fees related to the January 2026 divestiture of its legacy cellular telephone and mobile hotspot business.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 0 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • Moderate point. Forward-looking: it has not happened yet and may not happen.Expected continuing-operations net loss: approximately $1.3 million versus approximately $2.2 million.

Negative

  • None.
Expected net loss from continuing operations Approximately $1.3 million Three months ended September 30, 2026
Net loss from continuing operations Approximately $2.2 million Corresponding three-month period ended September 30, 2025
Prior-year interest expense Approximately $0.5 million Associated with promissory notes outstanding in the prior-year period and paid off in January 2026
Prior-year legal fees $0.4 million Incurred in connection with the January 2026 divestiture of the legacy cellular telephone and mobile hotspot business
mezzanine equity financial
"classification of such preferred stock as mezzanine equity"
Mezzanine equity is a layer of financing that sits between bank loans and full ownership, combining elements of borrowed money and equity. It often gives lenders higher potential returns in exchange for taking more risk, sometimes with the option to convert into ownership or receive extra payments; think of it as a middle seat that pays more because it’s less secure than front-row debt. Investors watch it because it affects a company’s debt risk, potential dilution of ownership, and expected returns.
permanent equity financial
"or permanent equity"
Permanent equity is capital provided to a company that has no fixed repayment date or required redemption, effectively staying on the balance sheet for the long term. It behaves like common equity but can carry specific rights or protections; think of it as a long-lasting financial foundation rather than a short-term loan. Investors care because it strengthens the company’s capital base, lowers refinancing pressure, and signals durable financial support.
net loss from continuing operations financial
"net loss from continuing operations"
Net loss from continuing operations is the amount by which a company's ongoing business activities produced a loss during a reporting period after subtracting all operating expenses, interest, taxes and other routine items, but before any results from discontinued businesses or one-time special items. It matters to investors because it isolates how the core business is performing and influences earnings per share and valuation, like measuring a car's fuel efficiency separate from costs of selling the car later.
promissory notes financial
"interest expense associated with promissory notes"
A promissory note is a written IOU in which a borrower promises to repay a specific amount to a lender, usually with stated interest and by a set date. Investors care because these notes are a formal debt claim—like holding a scheduled payment stream—so they affect a company’s borrowing costs, cash flow and credit risk; notes can be bought, sold or used as collateral, which influences liquidity and recoveries if things go wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When does SONM expect to file its delayed 10-Q?

DNA X, Inc. expects to file its Form 10-Q on or before the fifth calendar day following the prescribed due date. The report covers the three months ended September 30, 2026. The company attributed the delay to additional accounting work on a related-party preferred-stock issuance and its classification as mezzanine or permanent equity.

What net loss does SONM expect for the September 2026 quarter?

DNA X, Inc. expects net loss from continuing operations of approximately $1.3 million for the three months ended September 30, 2026, compared with approximately $2.2 million for the corresponding 2025 period. The company attributed the decrease to prior-year interest expense on notes paid off in January 2026 and legal fees related to its January 2026 divestiture.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 12b-25

 

NOTIFICATION OF LATE FILING

 

(Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K  
  ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

 

For Period Ended: September 30, 2026

 

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

 

For the Transition Period Ended: _____________

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

 

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

 

 

PART I — REGISTRANT INFORMATION

 

DNA X, Inc.

 

Full Name of Registrant

 

Sonim Technologies Inc.

 

Former Name if Applicable

 

4445 Eastgate Mall, Suite 200

 

Address of Principal Executive Office (Street and Number)

 

San Diego, CA 92121

 

City, State and Zip Code

 

 

 

 
 

 

PART II — RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

  (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
☒ (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
  (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III — NARRATIVE

 

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

DNA X, Inc. (the “Company”) is unable to file, without unreasonable effort or expense, its Quarterly Report on Form 10-Q for the three months ended September 30, 2026 (the “Form 10-Q”) within the prescribed time period. This delay resulted primarily from the need to determine the proper accounting for issuances of preferred stock to a related party for consideration consisting of cash and cancellation of outstanding indebtedness, and the need to determine classification of such preferred stock as mezzanine equity or permanent equity, which have required additional time to complete the Company’s financial close process for the three months ended September 30, 2026. The Company has been working diligently to make the required determinations and expects to file the Form 10-Q on or before the fifth calendar day following the prescribed due date.

 

PART IV — OTHER INFORMATION

 

(1) Name and telephone number of person to contact in regard to this notification.

 

Clay Crolius   (661)   618-7580
(Name)   (Area Code)   (Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes ☒ No ☐
   
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes ☒ No ☐
   
  If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

The Company anticipates that its results of operations for the three months ended September 30, 2026 will differ significantly from the corresponding three month period ended September 30, 2025 for the following reasons:

 

As discussed above in Part III, the Company is in the process of completing the preparation of its consolidated financial statements for the three month period ended September 30, 2026. The Company expects to report net loss from continuing operations of approximately $1.3 million for the three months ended September 30, 2026, compared to net loss from continuing operations of approximately $2.2 million for the three months ended September 30, 2025. The decrease in net loss from continuing operations was attributable to approximately $0.5 million in interest expense associated with promissory notes that were outstanding in the prior year period and paid off in January 2026 and $0.4 million in legal fees incurred during the prior year period in connection with the Company’s divestiture of its legacy cellular telephone and mobile hotspot business in January 2026.

 

 
 

 

DNA X, INC.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 17, 2026 By: /s/ Clay Crolius
  Name: Clay Crolius
  Title: Chief Financial Officer

 

 

 

Keep reading